Evidence map›Paper›PMID 24185616›Full record

ArticleNature immunology2013

T cell development requires constraint of the myeloid regulator C/EBP-α by the Notch target and transcriptional repressor Hes1.

Maria Elena De Obaldia, J Jeremiah Bell, Xinxin Wang, Christelle Harly, Yumi Yashiro-Ohtani, Jonathan H DeLong, Daniel A Zlotoff, Dil Afroz Sultana, Warren S Pear, Avinash Bhandoola

Abstract read
In one paragraph

Article in Nature immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. T Cell Development: From T-Lineage Specification to Intrathymic Maturation.Advances in experimental medicine and biology · 2025
    Review
  5. Transcriptional network dynamics in early T cell development.The Journal of experimental medicine · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Inflammation durably imprints memory CD4+ T cells.bioRxiv : the preprint server for biology · 2023
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Early Development of Innate Lymphoid Cells.Methods in molecular biology (Clifton, N.J.) · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Maria Elena De ObaldiaDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
J Jeremiah Bell
Xinxin Wang
Christelle Harly
Yumi Yashiro-Ohtani
Jonathan H DeLong
Daniel A Zlotoff
Dil Afroz Sultana
Warren S Pear
Avinash Bhandoola
University of Pennsylvania · US

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SHELLEY L BERGER · 1985 to 2026
$222.3M
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTEST32CA009140 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Malay Haldar, WARREN S PEAR · 1985 to 2026
$16.1M
TRAINING PROGRAM IN CELL AND MOLECULAR BIOLOGYT32GM007229 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BARTOLOMEI, MARISA S. · 1985 to 2023
$14.0M
Notch Regulation of Hematopoietic Cell FatesR01AI047833 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI JORDAN, MARTHA S, PEAR, WARREN S · 2000 to 2022
$7.4M
Early T lineage progenitorsR01AI059621 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BHANDOOLA, AVINASH · 2004 to 2013
$3.5M
Natural helper cells in allergic airway inflammationR21AI098428 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BHANDOOLA, AVINASH · 2012 to 2013
$426k
Early T Lineage ProgenitorsR56AI059621 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI GREENE, MARK I · 2014 to 2014
$400k
Recruitment of hematopoietic progenitors in the thymusF30HL099271 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ZLOTOFF, DANIEL · 2010 to 2012
$78k
Constraint of Myeloid Lineage Potential of Early T Progenitors by Hes1F32AI080091 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BELL, JAMES JEREMIAH · 2009 to 2009
$50k
NCI NIH HHS P30 CA016520NCI NIH HHS T32 CA-009140NCI NIH HHS T32 CA009140NHLBI NIH HHS F30 HL099271NHLBI NIH HHS F30-HL-099271NIAID NIH HHS 1-F32-AI-080091-01A1NIAID NIH HHS AI047833NIAID NIH HHS AI059621NIAID NIH HHS AI098428NIAID NIH HHS F32 AI080091NIAID NIH HHS R01 AI047833NIAID NIH HHS R01 AI059621NIAID NIH HHS R21 AI098428NIAID NIH HHS R56 AI059621NIGMS NIH HHS T32 GM-007229NIGMS NIH HHS T32 GM007229
6 · The paper itself

Abstract

Notch signaling induces gene expression of the T cell lineage and discourages alternative fate outcomes. Hematopoietic deficiency in the Notch target Hes1 results in severe T cell lineage defects; however, the underlying mechanism is unknown. We found here that Hes1 constrained myeloid gene-expression programs in T cell progenitor cells, as deletion of the myeloid regulator C/EBP-α restored the development of T cells from Hes1-deficient progenitor cells. Repression of Cebpa by Hes1 required its DNA-binding and Groucho-recruitment domains. Hes1-deficient multipotent progenitor cells showed a developmental bias toward myeloid cells and dendritic cells after Notch signaling, whereas Hes1-deficient lymphoid progenitor cells required additional cytokine signaling for diversion into the myeloid lineage. Our findings establish the importance of constraining developmental programs of the myeloid lineage early in T cell development.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCCAAT-Enhancer-Binding Protein-alphaCell LineCell LineageCells, CulturedCytokinesDendritic CellsFemaleFlow CytometryGene ExpressionHomeodomain ProteinsLymphopoiesisMiceMice, Inbred C57BLMice, KnockoutBasic Helix-Loop-Helix ProteinsCCAAT-Enhancer-Binding Protein-alphaCytokinesHes1 protein, mouseHomeodomain ProteinsReceptor, Notch1Transcription Factor HES-1

Identifiers

PMID24185616
PMCPMC4038953
OpenAlexW2042962276

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.